[HTML][HTML] Clinical characteristics of coronavirus disease 2019 in China
…, DSC Hui, B Du, L Li, G Zeng, KY Yuen… - New England journal …, 2020 - Mass Medical Soc
Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
Wuhan city and rapidly spread throughout China, data have been needed on the clinical …
[PDF][PDF] Structural and functional basis of SARS-CoV-2 entry by using human ACE2
…, S Niu, C Song, Z Zhang, G Lu, C Qiao, Y Hu, KY Yuen… - Cell, 2020 - cell.com
The recent emergence of a novel coronavirus (SARS-CoV-2) in China has caused significant
public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2…
public health concerns. Recently, ACE2 was reported as an entry receptor for SARS-CoV-2…
[HTML][HTML] Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019
has triggered an ongoing global pandemic of the severe pneumonia-like disease …
has triggered an ongoing global pandemic of the severe pneumonia-like disease …
[HTML][HTML] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
…, JP Cai, VCC Cheng, H Chen, CKM Hui, KY Yuen - The lancet, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with a novel coronavirus was
reported in Wuhan city, Hubei province, China. Affected patients were geographically linked …
reported in Wuhan city, Hubei province, China. Affected patients were geographically linked …
[HTML][HTML] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label …
…, TL Que, CS Lau, KH Chan, KKW To, KY Yuen - The Lancet, 2020 - thelancet.com
Background Effective antiviral therapy is important for tackling the coronavirus disease 2019
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …
[HTML][HTML] Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
The B.1.1.529/Omicron variant of SARS-CoV-2 was only recently detected in southern Africa,
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
but its subsequent spread has been extensive, both regionally and globally 1 . It is …
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort …
…, IFN Hung, Z Chen, H Chen, KY Yuen - The Lancet infectious …, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) causes severe community and nosocomial
outbreaks. Comprehensive data for serial respiratory viral load and serum antibody …
outbreaks. Comprehensive data for serial respiratory viral load and serum antibody …
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
A mysterious outbreak of atypical pneumonia in late 2019 was traced to a seafood wholesale
market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as …
market in Wuhan of China. Within a few weeks, a novel coronavirus tentatively named as …
Consistent detection of 2019 novel coronavirus in saliva
…, VCC Cheng, JFW Chan, KY Yuen - Clinical Infectious …, 2020 - academic.oup.com
The 2019 novel coronavirus (2019-nCoV) was detected in the self-collected saliva of 91.7%
(11/12) of patients. Serial saliva viral load monitoring generally showed a declining trend. …
(11/12) of patients. Serial saliva viral load monitoring generally showed a declining trend. …
[HTML][HTML] Antibody evasion properties of SARS-CoV-2 Omicron sublineages
The identification of the Omicron (B. 1.1. 529.1 or BA. 1) variant of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021 1 immediately …
syndrome coronavirus 2 (SARS-CoV-2) in Botswana in November 2021 1 immediately …